RBM22 Antibody [Biotin]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-22275B
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human, Mouse
Applications
Immunoprecipitation, Western Blot
Label
Biotin
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for RBM22 Antibody [Biotin]
Immunogen
The immunogen this antibody was made to, maps to a region between residue 175 and 225 of human RNA Binding Motif Protein 22 using the numbering given in entry NP_060517.1 (GeneID 55696).
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for RBM22 Antibody [Biotin]
Application
Recommended Usage
Immunoprecipitation
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: RBM22
Alternate Names
Cwc2, FLJ10290, fSAP47, functional spliceosome-associated protein 47, pre-mRNA-splicing factor RBM22, RNA binding motif protein 22, ZC3H16RNA-binding motif protein 22, Zinc finger CCCH domain-containing protein 16
Gene Symbol
RBM22
Additional RBM22 Products
Product Documents for RBM22 Antibody [Biotin]
Product Specific Notices for RBM22 Antibody [Biotin]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...